Analysis of online user discussions on Reddit associated with the transition of use between HIV PrEP therapy

In 2019, the U.S. Food and Drug Administration (FDA) approved emtricitabine and tenofovir alafenamide (Descovy) as another option for HIV pre-exposure prophylaxis (PrEP) prevention for high-risk adults and adolescents. With the introduction of this new PrEP, millions of current users on emtricitabin...

Descripción completa

Detalles Bibliográficos
Autores principales: Godinez, Hector, Xu, Qing, McMann, Tiana J., Li, Jiawei, Mackey, Timothy Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338828/
https://www.ncbi.nlm.nih.gov/pubmed/37457283
http://dx.doi.org/10.3389/fpubh.2023.1073813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338828/
https://www.ncbi.nlm.nih.gov/pubmed/37457283
http://dx.doi.org/10.3389/fpubh.2023.1073813

Ejemplares similares